DCC-3014 (Synonyms: DCC-3014) |
Katalog-Nr.GC39623 |
DCC-3014 (DCC-3014) ist ein dualer c-FMS (CSF-IR)- und c-Kit-Inhibitor, extrahiert aus dem Patent WO2014145025A2, Verbindungsbeispiel 10, und hat IC50-Werte von < 0,01 μM bzw. 0,1-1 μM .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1628606-05-2
Sample solution is provided at 25 µL, 10mM.
DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively[1].
[1]. Yumi Ahn, et al. 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities. WO2014145025A2.
Average Rating: 5
(Based on Reviews and 32 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *